(Q80215339)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17458434%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Sublingual immunotherapy in sensitized mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17458434%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

Jens Kildsgaard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17458434%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Jens Brimnes

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17458434%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Henrik Jacobi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17458434%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Kaare Lund

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17458434%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17458434%20AND%20SRC:MED&resulttype=core&format=json

Annals of Allergy, Asthma & Immunology

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17458434%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17458434%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17458434%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

366-372

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17458434%20AND%20SRC:MED&resulttype=core&format=json

Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study.

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

Effects on inflammation parameters of a double-blind, placebo controlled one-year course of SLIT in children monosensitized to mites

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

Sublingual allergen administration. I. Selective suppression of IgE production in rats by high allergen doses

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

Systemic immune responses induced by mucosal administration of lipopeptides without adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

Immunomodulation during sublingual therapy in allergic children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

Magic Lite design and development

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

Performance evaluation of a specific IgE assay developed for the ADVIA centaur® immunoassay system

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

Sublingual immunotherapy: a comprehensive review.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

Antigen presentation in the murine oral epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

Modified par j I allergen from P judaica pollen and its rate of absorption in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

Characteristics and immunobiology of grass pollen allergens.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

Characterization of immunoglobulin E responses in Balb/c mice against the major allergens of timothy grass (Phleum pratense) pollen

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

Comparison of recombinant timothy grass pollen allergens with natural extract for diagnosis of grass pollen allergy in different populations.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

Measurement of IgE antibodies against purified grass-pollen allergens (Phl p 1, 2, 3, 4, 5, 6, 7, 11, and 12) in sera of patients allergic to grass pollen

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

Skin test with a timothy grass (Phleum pratense) pollen extract vs. IgE to a timothy extract vs. IgE to rPhl p 1, rPhl p 2, nPhl p 4, rPhl p 5, rPhl p 6, rPhl p 7, rPhl p 11, and rPhl p 12: epidemiological and diagnostic data

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

The B-cell system of human mucosae and exocrine glands

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

Elevation of specific immunoglobulin A antibodies to both allergen and bacterial antigen in induced sputum from asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960884-8

7 January 2021

10.1016/S1081-1206(10)60884-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17458434%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference